ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,142.15
-0.06%
Dow Jones
38,778.10
0.49%
Gold vs US Dollar
2,318.76
-0.61%
Brent Oil
83.86
2.11%
Bitcoin
66,497.24
-0.21%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Lexaria Bioscience Corporation (LEXXW)

  7. Lexaria Bioscience Corporation (LEXXW) News

Lexaria Bioscience (LEXXW)

Lexaria Bioscience Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LEXXW
DateTimeSourceHeadlineSymbolCompany
12/06/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LEXXWLexaria Bioscience Corporation
11/06/202422:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:LEXXWLexaria Bioscience Corporation
03/06/202418:05Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:LEXXWLexaria Bioscience Corporation
15/05/202422:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LEXXWLexaria Bioscience Corporation
10/05/202422:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LEXXWLexaria Bioscience Corporation
10/05/202422:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LEXXWLexaria Bioscience Corporation
10/05/202422:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LEXXWLexaria Bioscience Corporation
10/05/202421:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LEXXWLexaria Bioscience Corporation
22/07/202113:18InvestorsHub NewsWireLexaria Summarizes Successful Antiviral Drug Studies and Ongoing StrategyNASDAQ:LEXXWLexaria Bioscience Corporation
21/07/202112:27InvestorsHub NewsWireLexaria's DehydraTECH Significantly Enhances Delivery of Colchicine in Study VIRAL-A20-3NASDAQ:LEXXWLexaria Bioscience Corporation
15/07/202113:14InvestorsHub NewsWireLexaria Completes Successful Antiviral Drug Molecular Characterization Study With Canada's National Research CouncilNASDAQ:LEXXWLexaria Bioscience Corporation
03/06/202113:05InvestorsHub NewsWireLexaria's DehydraTECH(TM)-Enabled Remdesivir and Ebastine Effectively Inhibit the COVID-19 SARS-CoV-2 VirusNASDAQ:LEXXWLexaria Bioscience Corporation
20/05/202112:16InvestorsHub NewsWireLexaria's Newest DehydraTECHTM 2.0 Formulation Tested in Study HYPER-A21-2 Demonstrates Its Strongest CBD Absorption..contNASDAQ:LEXXWLexaria Bioscience Corporation
12/05/202112:18InvestorsHub NewsWireLexaria Strengthens its International Patent Portfolio to 19 Patents GrantedNASDAQ:LEXXWLexaria Bioscience Corporation
06/05/202112:35InvestorsHub NewsWireLexaria Issues Successful Results from First 2021 Study, HYPER-A21-1NASDAQ:LEXXWLexaria Bioscience Corporation
14/04/202112:37InvestorsHub NewsWireLexaria's DehydraTECHTM Technology Utilized in Amari's "Everyday Calm," Named a Top CBD Product Pick by New Hope NetworkNASDAQ:LEXXWLexaria Bioscience Corporation
06/04/202112:16InvestorsHub NewsWireLexaria to Evaluate DehydraTECHTM in Multiple New MarketsNASDAQ:LEXXWLexaria Bioscience Corporation
24/03/202112:00InvestorsHub NewsWireLexaria Technology Generates Positive Stability Testing for World-Class Ready to Drink CBD BeveragesNASDAQ:LEXXWLexaria Bioscience Corporation
16/03/202111:39InvestorsHub NewsWireLexaria's Antiviral Drug Evaluation Program ProgressingNASDAQ:LEXXWLexaria Bioscience Corporation
15/03/202112:30InvestorsHub NewsWireRapid Progress in Hypertension Studies by LexariaNASDAQ:LEXXWLexaria Bioscience Corporation
 Showing the most relevant articles for your search:NASDAQ:LEXXW

Your Recent History

NASDAQ
ACQRU
Independence
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved